growth differentiation factor 6
Last updated 30 Sept 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The GDF6 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF6 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. The GDF6 protein is necessary for the formation of bones and joints in the limbs, skull, spine, chest, and ribs.
Video picks for GenesVideo library
Normal function
The GDF6 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF6 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. The GDF6 protein is necessary for the formation of bones and joints in the limbs, skull, spine, chest, and ribs.
The GDF6 protein is also involved in the development of the eyes, specifically the specialized light-sensitive tissue that lines the back of the eye called the retina. The GDF6 protein likely plays a role in the survival of specialized cells within the retina that detect light and colour (photoreceptor cells).
Conditions referring to this gene or chromosome
Other names
BMP13
CDMP2
GDF-6
growth/differentiation factor 6
KFS
KFS1
SCDO4
SGM1
Patient picks for Genes

Children's health
Restricted growth
Dwarfism is a medical or genetic condition which causes people to have restricted growth so that they are shorter than average. Specifically, people with dwarfism grow no higher than 4 ft 10 ins (147 cm). It can be due to literally hundreds of different causes, so the term actually includes many different medical conditions. The cause and type of dwarfism will therefore affect the outlook and problems that may be associated with it. The most common condition causing dwarfism is achondroplasia.
by Dr Hayley Willacy, FRCGP

Diet and nutrition
Biotin: do vitamins for hair growth really work?
If you are interested in hair growth supplements, then chances are you've heard of biotin. In recent years, this vitamin has grown in popularity and is widely available in the cosmetic industry. What exactly is biotin, and can it really promote longer, healthier hair?
by Amberley Davis

Cancer
Breast cancer facts and risk factors
Most cases of breast cancer occur by chance. However, breast cancer does occur more often than usual in some families because of their genetic makeup.
by Dr Colin Tidy, MRCGP

Treatment and medication
What factors are causing antimicrobial resistance?
Following a recent study by health economists at the University of Manchester and the University of Southern Denmark, the tremendous pressure GPs are currently working under has been linked to increasing broad-spectrum antibiotic prescribing in England. Because excess antibiotic prescribing has been closely linked to antibiotic resistance, there are concerns that these higher prescribing levels may be contributing to antimicrobial resistance.
by Emily Jane Bashforth

Heart health and blood vessels
Dilated cardiomyopathy causes: what are the risk factors?
Having dilated cardiomyopathy means that your heart muscle is weakened, which affects how your heart pumps blood around your body. There are a wide range of dilated cardiomyopathy causes, including genetics, other health conditions, alcohol consumption and a poor diet. While we can't control some of these risk factors, we can make positive lifestyle changes to reduce our risk of developing dilated cardiomyopathy.
by Amberley Davis

PCOS
What is polycystic ovary syndrome? | Patient Explainers
Polycystic ovary syndrome (PCOS) is common. It can cause period problems, reduced fertility, acne and excess hair growth. Many women with PCOS are also overweight. Find out more: [https://patient.info/health/polycystic-ovary-syndrome-leaflet](https://patient.info/health/polycystic-ovary-syndrome-leaflet) Follow Patient: Website: [https://patient.info/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest: [https://uk.pinterest.com/patient/](https://uk.pinterest.com/patient/) Instagram: [https://www.instagram.com/patient.info/](https://www.instagram.com/patient.info/)
by Prof Lesley Regan, FRCOG
Related patient information and medicines

Patient information leaflet
Throat cancer
...e more likely you are to develop throat (laryngeal) cancer: Drinking alcohol makes you about two and a half times more likely to develop throat (laryngeal) cancer,Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer.

Patient information leaflet
Penile cancer
The exact reason why a cell becomes cancerous is unclear. It is thought that something damages or alters certain genes in the cell. This makes the cell abnormal and multiply 'out of control'. See the separate leaflet called Causes of cancer for more details. How common is penile cancer. Penile cancer is rare in the UK. It occurs in fewer than 1 in.

Patient information leaflet
Acromegaly
Acromegaly is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. The most noticeable symptoms are that your hands and feet become larger and features of your face may become more prominent. The cause is usually a small non-cancerous growth.

Patient information leaflet
Vulval intraepithelial neoplasia
Vulval intraepithelial neoplasia (VIN) is a skin condition of the vulva. It is not a cancer, but it can turn into cancer if not treated. What is vulval intraepithelial neoplasia. Vulval intraepithelial neoplasia (VIN) is a skin disorder that affects your vulva. (See the separate leaflet called Gynaecological Cancer Gynaecological cancer for more.

Patient information leaflet
Diabetic retinopathy
Stage 3: proliferative retinopathy Proliferative retinopathy is the advanced diabetic retinopathy that occurs when damaged blood vessels in the retina make chemicals called growth factors. These can cause new tiny blood vessels to grow (prolif... Eye checks for diabetic retinopathy NICE guidance on screening and referral for diabetic eye problems.

Patient information leaflet
Turner syndrome
It should definitely be started as soon as it is clear that a child is not growing normally due to Turner syndrome. Growth hormone replacement therapy has been shown to increase the final height by as much as 10 cm. Growth hormone therapy is generally continued until a child reaches a bone age of 14. This means that her bones are the same as the.
Further reading and references
- growth differentiation factor 6; MedlinePlus, National Library of Medicine.
- Asai-Coakwell M, March L, Dai XH, Duval M, Lopez I, French CR, Famulski J, De Baere E, Francis PJ, Sundaresan P, Sauve Y, Koenekoop RK, Berry FB, Allison WT, Waskiewicz AJ, Lehmann OJ. Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophies. Hum Mol Genet. 2013 Apr 1;22(7):1432-42. doi: 10.1093/hmg/dds560. Epub 2013 Jan 9.
- Frikha R. Klippel-Feil syndrome: a review of the literature. Clin Dysmorphol. 2020 Jan;29(1):35-37. doi: 10.1097/MCD.0000000000000301.
- Jae-Min Park A, Nelson SE, Mesfin A. Klippel-Feil Syndrome: Clinical Presentation and Management. JBJS Rev. 2022 Feb 15;10(2). doi: 10.2106/JBJS.RVW.21.00166.
- Litrenta J, Bi AS, Dryer JW. Klippel-Feil Syndrome: Pathogenesis, Diagnosis, and Management. J Am Acad Orthop Surg. 2021 Nov 15;29(22):951-960. doi: 10.5435/JAAOS-D-21-00190.
- Menger RP, Rayi A, Notarianni C. Klippel Feil Syndrome. 2024 May 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK493157/
- Portnoy ME, McDermott KJ, Antonellis A, Margulies EH, Prasad AB; NISC Comparative Sequencing Program; Kingsley DM, Green ED, Mortlock DP. Detection of potential GDF6 regulatory elements by multispecies sequence comparisons and identification of a skeletal joint enhancer. Genomics. 2005 Sep;86(3):295-305. doi: 10.1016/j.ygeno.2005.05.003.
- Pregizer S, Mortlock DP. Control of BMP gene expression by long-range regulatory elements. Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):509-15. doi: 10.1016/j.cytogfr.2009.10.011. Epub 2009 Nov 8.
- Tassabehji M, Fang ZM, Hilton EN, McGaughran J, Zhao Z, de Bock CE, Howard E, Malass M, Donnai D, Diwan A, Manson FD, Murrell D, Clarke RA. Mutations in GDF6 are associated with vertebral segmentation defects in Klippel-Feil syndrome. Hum Mutat. 2008 Aug;29(8):1017-27. doi: 10.1002/humu.20741.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

